Background. The association between chronic kidney involvement and sickle cell disease (SCD) has been well characterized, but our knowledge on acute kidney injury (AKI) in relation to SCD remains limited. Methods. We retrospectively assessed 254 episodes of vaso-occlusive complication in 161 SCD patients who were admitted to our hospital: these included 174 episodes of painful crisis (PC), 58 episodes of moderate acute chest syndrome (ACS) and 22 episodes of severe ACS. Results. The overall incidence of AKI [defined according to Acute Kidney Injury Network (AKIN) criteria] during vaso-occlusive complications was low (4.3%) but seemed to be related to its severity: 2.3% for PC vs 6.9% for moderate ACS and 13.6% for severe ACS (P = 0.03). This finding led us prospectively to look at specific risk factors for AKI occurrence in SCD patients admitted to our intensive care unit for severe ACS and, in particular, the possible link between AKI and haemodynamic status (transthoracic echocardiography). Among patients with severe ACS, those with AKI displayed significantly greater aminotransferases, bilirubin and lactate dehydrogenase levels than patients without AKI. Echocardiography identified higher systolic pulmonary artery pressure in patients with AKI than in those without, whereas the cardiac index was similar between groups. Conclusions. AKI incidence during vaso-occlusive complications of SCD is relatively low (<5%) and appears to be confined to patients with ACS and pulmonary hypertension. These findings suggest a pathophysiological process involving right ventricular dysfunction and venous congestion.
Introduction
Sickle-cell disease (SCD), one of the most frequent haemoglobinopathies, is characterized by chronic haemolysis, recurrent episodes of vaso-occlusive events affecting microcirculation, and chronic organ damage and dysfunction involving the kidney [1, 2] . Chronic sickle cell nephropathy includes various clinical manifestations, such as proteinuria and a progressive decline in the glomerular filtration rate leading to end-stage renal disease, which is a major mortality risk factor in adult patients with SCD [3] [4] [5] [6] [7] . Cardiopulmonary complications were recently reported as the leading cause of premature deaths in SCD patients [8] . Although renal failure was not found as a direct cause of death in the previous study, renal insufficiency occurred significantly more frequently in deceased subjects as compared to survivors [8] .
In contrast to chronic sickle cell nephropathy, our knowledge on acute kidney injury (AKI) in SCD patients is limited [9] . To date, there are no studies reporting the exact incidence and risk factors for AKI in SCD patients hospitalized for vaso-occlusive complications, including painful crisis (PC) or acute chest syndrome (ACS). It has been recently shown in a mouse model of SCD that hypoxia/reoxygenation can induce kidney damage with marked renal vascular congestion [10] . The kidney damage was accompanied by changes in renal haemodynamics (decrease in mean renal blood flow) but was also accompanied by changes in systemic and pulmonary haemodynamics (decrease in pulmonary blood flow and cardiac output) [10, 11] . Vaso-occlusive complications are associated with ischaemia and reperfusion mimicking experimental hypoxia/reoxygenation, as well as haemody-namic compromise in some patients [12] . We sought to determine if AKI [according to Acute Kidney Injury Network (AKIN) criteria] is a frequent finding during vaso-occlusive complications and if it is related to haemodynamic alterations. Therefore, we retrospectively studied a large cohort of SCD patients hospitalized in our institution for vaso-occlusive complications (PC and ACS) to estimate the incidence and to study the risk factors for AKI at hospital admission. We also prospectively analysed, in a group of patients hospitalized in the intensive care unit (ICU) for severe ACS, the possible association between haemodynamic alterations (assessed using transthoracic echocardiography) and the occurrence of AKI at ICU admission.
Materials and methods

Patient population
This study was conducted in Henri Mondor University Teaching Hospital in Creteil, France. This hospital houses a Sickle Cell Disease Centre. Firstly, we analysed retrospectively the clinical and biological data from consecutive SCD patients hospitalized in our institution for vaso-occlusive complications between 1 January 2004 and 31 December 2004 to determine the incidence and risk factors for AKI in this population. Patients were divided into three groups based on the severity of the vasoocclusive complication: uncomplicated PC was defined as an episode of pain that affected long bones, ribs, pelvis, sternum or the abdomen without pulmonary symptoms; moderate ACS was based on the presence of fever or chest pain accompanied by the appearance of new pulmonary infiltrates on the chest X-ray; and severe ACS was diagnosed when ACS was accompanied by signs of severity requiring ICU admission as previously reported [12] . Baseline characteristics and laboratory values (measured during the 3 months preceding hospitalization) were recorded for all patients. The serum creatinine level was also recorded at the followup consultation (a month later) in patients who were diagnosed with AKI during hospitalization. Secondly, we prospectively evaluated patients admitted to the ICU for severe ACS between 1 January 2004 and 31 September 2006 to assess the possible link between their haemodynamic profiles (assessed using echocardiography) and the occurrence of AKI. All patients prospectively evaluated gave their oral and written informed consents to participate to this study which was approved by our hospital's ethical committee.
AKI definition
Serum creatinine levels were measured by Jaffe kinetic method (Advia 1650, Siemens ® ). AKI was defined according to AKIN criteria [13] . AKIN stratifies AKI into three stages (stages 1, 2 and 3) according to the severity of the percentage change in the serum creatinine (stage 1 is defined as an increase in serum creatinine of ≥26.4 μmol/L or increase to ≥150-200% from baseline, stage 2 as an increase in serum creatinine to >200-300% from baseline and stage 3 as an increase in serum creatinine to >300% from baseline or serum creatinine of ≥354 μmol/L with an acute increase of at least 44 μmol/L). Serum creatinine levels were measured at hospital admission or ICU admission (while performing echocardiography) and were compared with the baseline value (the lowest serum creatinine level measured during the 3 months preceding hospitalization). Albumin excretion rate (AER) expressed as milligram per gram creatinine was defined as microalbuminuria (AER 30-299 mg/g creatinine) or macroalbuminuria (AER ≥300 mg/g creatinine) [3] . Patients without available biological data allowing AKI classification and those with pre-existing chronic kidney damage [defined as a glomerular filtration rate <60 mL/min/1.73 m 2 according to Modification of Diet in Renal Disease (MDRD) formula] were excluded from the analysis.
Echocardiography
Transthoracic echocardiography was performed within 24 h of ICU admission in all patients with severe ACS with the use of the Sonos 5500 or Envisor systems (Philips Ultrasound, Bothell, USA). Cardiac measurements were performed as previously described, according to the guidelines of the American Society of Echocardiography, with assessment of central venous pressure (using inferior vena cava collapse), pulmonary artery pressure (using tricuspid regurgitant jet velocity), left ventricular diastolic pressure [using the ratio between peak velocity of E wave and A wave (E/A ratio)], kinetics of the interventricular septum, left ventricular ejection fraction, stroke index and cardiac index [12] .
Statistical analysis
Data were analysed using the SPSS Base 13.0 statistical software package (SPSS Inc, Chicago, IL). Continuous data were expressed as median (25th-75th percentiles) and were compared using the KruskalWallis one-way analysis of variance test, the Wilcoxon paired test for related variables and the Mann-Whitney test for independent variables. Categorical variables, expressed as percentages, were analysed with a chisquare test or a Fisher's exact test. Correlations were tested using Spearman's method. A P-value of <0.05 in a bilateral analysis was considered significant.
Results
Incidence and risk factors for AKI during vaso-occlusive complications
A total of 254 episodes of vaso-occlusive complications were assessed in 161 patients, including 174 episodes of uncomplicated PC (in 103 patients), 58 episodes of moderate ACS (in 42 patients) and 22 episodes of severe ACS (in 16 patients). At hospital admission, the white blood cell count and aminotransferase, bilirubin and lactate dehydrogenase levels were significantly higher for ACS episodes than for uncomplicated PC episodes (Table 1) . Overall, AKI occurred in 11 (4.3%) episodes (corresponding to 11 AKI in sickle patients and its relation to pulmonary hypertension 2525 different patients) and included 10 cases in stage 1 and one case in stage 2. Two patients with AKI had received nonsteroidal anti-inflammatory drugs before hospital admission. No patient with AKI had received radiocontrast agent before AKI occurrence. The incidence of AKI was 2.3% during uncomplicated PC (four episodes), 6.9% during moderate ACS (four episodes) and 13.6% during severe ACS episodes (three episodes) (P = 0.03). Laboratory values at hospital admission were similar between patients who developed AKI and those who did not, except for plasma creatinine (Table 2) . Patients who developed AKI during at least one vaso-occlusive episode had lower baseline haemoglobin levels and higher baseline white cell counts and lactate dehydrogenase levels than other patients (Table 3) . AER measurements before hospital admission were available in seven of the 11 patients with AKI: one patient had macroalbuminuria (AER of 550 mg/g of creatinine), two patients had microalbuminuria (AER of 70 and 180 mg/g of creatinine, respectively) and four patients had no significant glomerular involvement. The renal function recovered at the follow-up assessment in 9 of 11 patients who developed AKI during hospitalization; in contrast, one patient remained with increased creatinine values, and another patient developed chronic renal failure requiring long-term dialysis (Figure 1 ). In the last patient, a renal biopsy examination revealed severe acute tubular necrosis lesions associated with typical lesions of focal segmental glomerulosclerosis. 
Association between haemodynamic profile and AKI occurrence in patients with severe ACS
We assessed 65 episodes of severe ACS in 52 patients admitted to our ICU to determine the putative haemodynamic factors related to AKI in SCD patients. AKI occurred during six (9.2%) of these episodes (corresponding to six different patients). None of these patients displayed severe sepsis or rhabdomyolysis as predisposing factors to AKI. Among patients with AKI, only one had received non-steroidal anti-inflammatory drugs to treat vaso-occlusive crisis prior to ICU admission. The first-day fluid volume was identical between patients with AKI and others: 2500 (1750-3000) vs 2750 (2375-3000) mL (P = 0.48). Patients with AKI had higher aminotransferase, bilirubin and lactate dehydrogenase levels at ICU admission than patients without AKI (Table 4 ). Blood gas analysis revealed identical PaO 2 /FiO 2 and PaCO 2 values between groups (Table 4) . Baseline characteristics were identical whether the AKI occurred during a severe ACS episode or not (data not shown). Among the six patients with AKI, one patient had microalbuminuria at baseline (AER of 150 mg/g of creatinine), whereas there was no significant glomerular involvement in four other patients, and there were missing data in one patient. The maximal creatinine value during ICU stay was significantly higher in AKI patients as compared to others: 156 (145-267) vs 71 (62-86) μmol/L (P < 0.01). Echocardiographic findings during severe ACS episodes are reported in Table 5 . Patients with AKI had lesser inferior vena cava collapse, higher tricuspid regurgitant jet velocity and higher systolic pulmonary artery pressure than patients without, whereas the E/A ratio, left ventricle ejection fraction, stroke index and cardiac index were similar between both groups (Table 5 ). At follow-up, the renal function recovered in three of the six patients who developed AKI during ICU stay, whereas two patients remained with increased creatinine values, and another patient died ( Figure E1 ; see online supplementary material for a colour version of this figure).
Discussion
The main finding of our study is that the overall incidence of AKI during vaso-occlusive complications is low (<5%) and that it seems to be confined to patients with ACS and pulmonary hypertension. Thus, right ventricular dysfunction may be involved in the pathogenesis of AKI during vaso-occlusive complications of SCD. Over the past decade, important advances have been made in the pathogenesis of acute renal failure, implicating tubular epithelial cell injury, inflammatory process and renal vascular endothelial dysfunction [14] . Patients with SCD are theoretically more sensitive to AKI associated with renal microvascular occlusion [7] . Recent experimental data using mouse models of SCD have demonstrated renal vessel congestion, including peritubular capillaries and capillary loops of the glomeruli during hypoxia-reox- AKI in sickle patients and its relation to pulmonary hypertension 2527 ygenation injury [10, 15] . Our study demonstrates that vaso-occlusive complications are associated with AKI in only a few cases (overall incidence <5%). These results are in contrast to those of Sklar et al. who reported acute renal failure in 10% of 116 hospitalized SCD patients [9] . The difference between our study and the study of Sklar et al. may be related to the fact that the crisis was limited in the majority of our patients. In addition, Sklar et al. used all available creatinine values during hospitalization to define renal failure, whereas we defined AKI at hospital admission. Moreover, Sklar et al. evaluated all hospitalizations regardless of the reason for admission, whereas our study focused on vaso-occlusive complications (PC and ACS). The absence of an increase in creatinine during the majority of vaso-occlusive episodes (particularly during uncomplicated PCs) may have several explanations. First, the higher glomerular filtration rate observed in SCD patients may hide creatinine increases to a certain extent [16] . Interestingly, Nath et al. recently reported in a SCD animal model that, despite major renal lesions, the mice had lower plasma creatinine levels, reflecting a higher glomerular filtration rate [15] . Second, the occurrence of hypoxia-reoxygenation injury may not be the sole determinant of AKI in these patients. Hyperhaemolysis, which is common during vasoocclusive complications, may contribute to the AKI observed in our patients [17] . In fact, we found higher levels of lactate dehydrogenase, bilirubin and aminotransferases at ICU admission in patients with AKI during severe ACS. In addition, there was a trend towards lower total haemoglobin levels in this group as compared to patients without AKI, but we did not measure plasma haemoglobin. We also observed a close relationship between the risk of AKI and the type and severity of vaso-occlusive complications. In fact, the incidence of AKI varied from 2.3% during uncomplicated PC to 13.6% during severe ACS. This suggests that lung injury and/or systemic haemodynamics may be involved in the initiation of AKI in SCD patients.
Some patients with AKI had received non-steroidal antiinflammatory drugs to treat vaso-occlusive crisis. In these patients, we cannot exclude a toxic effect of these drugs on the kidney, especially in the case of decreased renal blood flow. Decreases in renal blood flow are an important factor in the pathophysiology of acute ischaemic renal failure [14] . This decrease in renal blood flow may be related to the decrease in the cardiac index as observed in AKI associated with advanced left ventricular failure [18] . Volume depletion in SCD patients may induce a decrease in the cardiac index, resulting in acute renal failure, as reported by Sklar et al. [9] . However, Sklar et al. also showed that acute renal failure may occur in these patients despite a preserved cardiac index [9] . This observation is consistent with the results of our haemodynamic study. We found no difference in left ventricular pressures or cardiac indexes between patients with or without AKI. In contrast, pulmonary and right heart pressures were significantly higher, and cor pulmonale was more frequent in AKI patients than in non-AKI patients. In addition, AKI patients exhibited a greater liver enzyme level increase, compatible with some degree of hepatic injury secondary to cardiac hepatopathy. Of note, the increase in bilirubin observed in some patients may have, in some cases, underestimated the creatinine level measured using the Jaffe method. The implication of right heart failure in AKI has been suggested by several authors [19] . One study showed an inverse correlation between renal blood flow and mean pulmonary pressure in patients with chronic heart failure [20] . Damman et al. recently demonstrated in patients with pulmonary hypertension and mildly impaired left and right ventricular functions that only 'high' right atrial pressure and 'low' renal blood flow were independent predictors of altered renal glomerular filtration rate [21] . Thus, within a context of severe ACS, our results suggest that AKI is probably related to pulmonary hypertension, leading to renal venous pressure increases and congestion. Of note, renal failure and pulmonary hypertension have both been reported as independent risk factors for death in patients with steady-study SCD [4, 22] .
Our study has some limitations. First, we are unable to definitively draw conclusions about the specific mechanisms involved in patients with AKI in this study because a renal haemodynamic study was not performed, and urinary parameters were not available. Second, patients were not histologically assessed during the acute phase, and it is difficult to establish a precise clinicopathological correla- tion between AKI and vaso-occlusive complications. Third, the limited sample size of the AKI subgroup somewhat weakens the strength of the comparison between AKI patients and others, especially in the severe ACS cohort. Fourth, the multiple comparisons used may increase the false discovery rate in our study. However, the alpha risk (type I error) was particularly low concerning our main finding of significant right heart involvement and hepatolysis in AKI patients as compared to others. Fifth, despite the fact that there is no genetic peculiarity of SCD in France compared to the classical description, there is now some evidence that, within a given group of sickle cell patients, some genetic polymorphisms (that were not assessed in the present work) may be associated with more or less severity or even with some specific complications. In addition, we did not assess patients with pre-existing renal failure. Whether SCD patients with chronic renal failure experience exacerbations during vaso-occlusive complications should be addressed in further investigations. Lastly, the retrospective nature of the study suffers from limitations inherent to this type of approach.
In conclusion, we demonstrated that AKI is a rare complication of vaso-occlusive episodes of SCD and appears to be confined to patients with ACS and pulmonary hypertension. Its pathogenesis may therefore implicate some degree of venous renal congestion.
